Category : Orthopedic Oncology / Orthopaedics
Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan Kettering Cancer Center (MSK) has found that abemaciclib (Verzenio®) - a drug already approved for certain breast cancers - can significantly slow the growth of DDLS.
Source : MSKCC
On : 31-Jul-2026